Original Research

Sodium-Glucose Cotransporter 2 Inhibitor Use Among Individuals Age <65 with Type 2 Diabetes and Heart Failure with Reduced Ejection Fraction: A Cost–Benefit Analysis

Glover S, Borrego ME, Ray GM, Roberts MH

ClinicoEconomics and Outcomes Research 2022, 14:465-477

Published Date: 9 July 2022